These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19692699)

  • 1. 5-year survival of patients with AIDS receiving antiretroviral therapy in Haiti.
    Leger P; Charles M; Severe P; Riviere C; Pape JW; Fitzgerald DW
    N Engl J Med; 2009 Aug; 361(8):828-9. PubMed ID: 19692699
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiretroviral therapy in a thousand patients with AIDS in Haiti.
    Severe P; Leger P; Charles M; Noel F; Bonhomme G; Bois G; George E; Kenel-Pierre S; Wright PF; Gulick R; Johnson WD; Pape JW; Fitzgerald DW
    N Engl J Med; 2005 Dec; 353(22):2325-34. PubMed ID: 16319381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 10-Year Survival of Patients with AIDS Receiving Antiretroviral Therapy in Haiti.
    Pierre S; Jannat-Khah D; Fitzgerald DW; Pape J; McNairy ML
    N Engl J Med; 2016 Jan; 374(4):397-8. PubMed ID: 26816026
    [No Abstract]   [Full Text] [Related]  

  • 4. Timing of initiation of antiretroviral drugs during tuberculosis therapy.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray A; Gengiah T; Nair G; Bamber S; Singh A; Khan M; Pienaar J; El-Sadr W; Friedland G; Abdool Karim Q
    N Engl J Med; 2010 Feb; 362(8):697-706. PubMed ID: 20181971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy in AIDS patients with CMV disease: impact on the survival and long-term treatment outcome.
    Sungkanuparph S; Chakriyanuyok T; Butthum B
    J Infect; 2008 Jan; 56(1):40-3. PubMed ID: 18037166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Survival time of HIV/AIDS cases and influencing factors in Gansu province, 1997-2018].
    Li J; Li H; Yu AL; Wang B; Wang XR
    Zhonghua Liu Xing Bing Xue Za Zhi; 2019 Nov; 40(11):1398-1402. PubMed ID: 31838811
    [No Abstract]   [Full Text] [Related]  

  • 7. Assessing the contribution of the immune reconstitution inflammatory syndrome to mortality in developing country antiretroviral therapy programs.
    Davies MA; Meintjes G
    Clin Infect Dis; 2009 Sep; 49(6):973-5. PubMed ID: 19673616
    [No Abstract]   [Full Text] [Related]  

  • 8. Care of Critically Ill Patients with Human Immunodeficiency Virus.
    Garland JM; Levinson A; Wing E
    Ann Am Thorac Soc; 2020 Jun; 17(6):659-669. PubMed ID: 32216642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality rate and influencing factors among index partners of HIV discordant couples in the context of antiretroviral therapy, Zhumadian, Henan province, 2008-2014].
    Chen FF; Wang L; Jin SS; Xu F; Wang L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Jul; 37(7):955-9. PubMed ID: 27453104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causes and characteristics of death among HIV-1 infected patients with immunovirologic response to antiretroviral treatment].
    May T; Lewden C; Bonnet F; Heripret L; Bevilacqua S; Jougla E; Costagliola D; Morlat P; Salmon D; Chêne G;
    Presse Med; 2004 Dec; 33(21):1487-92. PubMed ID: 15637794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and immunologic response without decrease in virus load in patients with AIDS after 24 months of highly active antiretroviral therapy.
    Mezzaroma I; Carlesimo M; Pinter E; Muratori DS; Di Sora F; Chiarotti F; Cunsolo MG; Sacco G; Aiuti F
    Clin Infect Dis; 1999 Dec; 29(6):1423-30. PubMed ID: 10585790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decrease in hospitalization and mortality rates among children with perinatally acquired HIV type 1 infection receiving highly active antiretroviral therapy.
    Viani RM; Araneta MR; Deville JG; Spector SA
    Clin Infect Dis; 2004 Sep; 39(5):725-31. PubMed ID: 15356789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interruption of combination antiretroviral therapy and risk of clinical disease progression to AIDS or death.
    Holkmann Olsen C; Mocroft A; Kirk O; Vella S; Blaxhult A; Clumeck N; Fisher M; Katlama C; Phillips AN; Lundgren JD;
    HIV Med; 2007 Mar; 8(2):96-104. PubMed ID: 17352766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of mortality among adult people living with HIV/AIDS on antiretroviral therapy at Suhul Hospital, Tigrai, Northern Ethiopia: a retrospective follow-up study.
    Misgina KH; Weldu MG; Gebremariam TH; Weledehaweria NB; Alema HB; Gebregiorgis YS; Tilahun YG
    J Health Popul Nutr; 2019 Nov; 38(1):37. PubMed ID: 31783924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective long-term outcomes of a cohort of Ugandan children with laboratory monitoring during antiretroviral therapy.
    Kekitiinwa A; Asiimwe AR; Kasirye P; Korutaro V; Kitaka S; Maganda A; Madalon M; Graziano FM
    Pediatr Infect Dis J; 2012 Aug; 31(8):e117-25. PubMed ID: 22581223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lifetime cost of current human immunodeficiency virus care in the United States.
    Schackman BR; Gebo KA; Walensky RP; Losina E; Muccio T; Sax PE; Weinstein MC; Seage GR; Moore RD; Freedberg KA
    Med Care; 2006 Nov; 44(11):990-7. PubMed ID: 17063130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Simultaneous treatment of HIV and tuberculosis is possible and necessary].
    von der Maase S; Gerstoft J; Wejse C
    Ugeskr Laeger; 2014 Feb; 176(6A):V03130163. PubMed ID: 25347439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality rate among HIV-positive children on ART in Northwest Ethiopia: a historical cohort study.
    Alebel A; Engeda EH; Kelkay MM; Petrucka P; Kibret GD; Wagnew F; Asmare G; Bitew ZW; Ketema DB; Gedif G; Temesgen B; Hibstie YT; Melkamu MW; Eshetie S
    BMC Public Health; 2020 Aug; 20(1):1303. PubMed ID: 32854692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cause-specific mortality and the contribution of immune reconstitution inflammatory syndrome in the first 3 years after antiretroviral therapy initiation in an urban African cohort.
    Castelnuovo B; Manabe YC; Kiragga A; Kamya M; Easterbrook P; Kambugu A
    Clin Infect Dis; 2009 Sep; 49(6):965-72. PubMed ID: 19673615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004.
    Schneider MF; Gange SJ; Williams CM; Anastos K; Greenblatt RM; Kingsley L; Detels R; Muñoz A
    AIDS; 2005 Nov; 19(17):2009-18. PubMed ID: 16260908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.